Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Calandra

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Medecine Sciences : M/S|January 4, 2017
[Macrophage migration inhibitory factor (MIF), a regulator of neonatal innate immune response]Éric Giannoni, Anina Schneider, Thierry Calandra, et al.
The Journal of Infectious Diseases|June 7, 2003
Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsisThierry Calandra, Céline Froidevaux, Christian Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2005
A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancerMurat Akova, Marianne Paesmans, Thierry Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Reply to Pasqualotto and SukiennikLaurence Senn, Thierry Calandra, Jacques Bille, et al.
Critical Care Medicine|November 16, 2004
Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based reviewPierre-Yves Bochud, Marc Bonten, Oscar Marchetti, et al.
The Lancet. Infectious Diseases|July 25, 2007
Innate immunogenetics: a tool for exploring new frontiers of host defencePierre-Yves Bochud, Murielle Bochud, Amalio Telenti, et al.
Revue Medicale De La Suisse Romande|August 6, 2004
[New therapeutic strategies in severe sepsis and septic shock]Mauro Oddo, Marie-Denise Schaller, Thierry Calandra, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Changes in the epidemiological landscape of invasive candidiasisFrederic Lamoth, Shawn R Lockhart, Elizabeth L Berkow, et al.
Revue Medicale Suisse|April 13, 2022
Laurent Kaiser, Pauline Vetter, Alexandra Calmy, et al.
The Journal of Infection|March 16, 2021
Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shockSandra A Asner, Florian Desgranges, Irene T Schrijver, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Medecine Sciences : M/S|January 4, 2017
[Macrophage migration inhibitory factor (MIF), a regulator of neonatal innate immune response]Éric Giannoni, Anina Schneider, Thierry Calandra, et al.
The Journal of Infectious Diseases|June 7, 2003
Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsisThierry Calandra, Céline Froidevaux, Christian Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2005
A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancerMurat Akova, Marianne Paesmans, Thierry Calandra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Reply to Pasqualotto and SukiennikLaurence Senn, Thierry Calandra, Jacques Bille, et al.
Critical Care Medicine|November 16, 2004
Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based reviewPierre-Yves Bochud, Marc Bonten, Oscar Marchetti, et al.
The Lancet. Infectious Diseases|July 25, 2007
Innate immunogenetics: a tool for exploring new frontiers of host defencePierre-Yves Bochud, Murielle Bochud, Amalio Telenti, et al.
Revue Medicale De La Suisse Romande|August 6, 2004
[New therapeutic strategies in severe sepsis and septic shock]Mauro Oddo, Marie-Denise Schaller, Thierry Calandra, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Changes in the epidemiological landscape of invasive candidiasisFrederic Lamoth, Shawn R Lockhart, Elizabeth L Berkow, et al.
Revue Medicale Suisse|April 13, 2022
Laurent Kaiser, Pauline Vetter, Alexandra Calmy, et al.
The Journal of Infection|March 16, 2021
Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shockSandra A Asner, Florian Desgranges, Irene T Schrijver, et al.
Pageof 19